cnbc.com
🌐 75% Global Worthiness
Dow Jones Stocks Poised for Growth in 2025: Merck and Nvidia Lead the Way
Wall Street analysts predict strong gains for select Dow Jones stocks in 2025, with Merck leading at 32% projected upside due to its Keytruda drug and pipeline, while Nvidia projects 28% growth despite recent market corrections; other pharma stocks show mixed outlooks.
Dow Jones Stocks Poised for Growth in 2025: Merck and Nvidia Lead the Way
Wall Street analysts predict strong gains for select Dow Jones stocks in 2025, with Merck leading at 32% projected upside due to its Keytruda drug and pipeline, while Nvidia projects 28% growth despite recent market corrections; other pharma stocks show mixed outlooks.
Progress
40% Bias Score
Good Health and Well-being